137 related articles for article (PubMed ID: 38923874)
1. Viral Mimicking Polyplexes as Hierarchical Unpacking Vectors for Rheumatoid Arthritis Treatment.
Zhu H; Huang D; Wang J; Zhao Y; Sun L
Adv Sci (Weinh); 2024 Jun; ():e2402888. PubMed ID: 38923874
[TBL] [Abstract][Full Text] [Related]
2. Viral mimicking ternary polyplexes: a reduction-controlled hierarchical unpacking vector for gene delivery.
He Y; Nie Y; Cheng G; Xie L; Shen Y; Gu Z
Adv Mater; 2014 Mar; 26(10):1534-40. PubMed ID: 24757715
[TBL] [Abstract][Full Text] [Related]
3. Stem Cell Mimicking Nanoencapsulation for Targeting Arthritis.
Shin MJ; Park JY; Lee DH; Khang D
Int J Nanomedicine; 2021; 16():8485-8507. PubMed ID: 35002240
[TBL] [Abstract][Full Text] [Related]
4. Glucocorticoid-loaded pH/ROS dual-responsive nanoparticles alleviate joint destruction by downregulating the NF-κB signaling pathway.
Lu Y; Zhou J; Wang Q; Cai J; Yu B; Dai Q; Bao Y; Chen R; Zhang Z; Zhang D; Hou T
Acta Biomater; 2023 Jul; 164():458-473. PubMed ID: 37072065
[TBL] [Abstract][Full Text] [Related]
5. Peptide targeting improves the delivery and therapeutic index of glucocorticoids to treat rheumatoid arthritis.
Wu X; Guo H; Gao H; Li Y; Hu X; Kowalke MA; Li YX; Wei Y; Zhao J; Auger J; Binstadt BA; Pang HB
J Control Release; 2024 Apr; 368():329-343. PubMed ID: 38431094
[TBL] [Abstract][Full Text] [Related]
6. Intra-articular delivery of AAV vectors encoding PD-L1 attenuates joint inflammation and tissue damage in a mouse model of rheumatoid arthritis.
Li W; Sun J; Feng SL; Wang F; Miao MZ; Wu EY; Wallet S; Loeser R; Li C
Front Immunol; 2023; 14():1116084. PubMed ID: 36936967
[TBL] [Abstract][Full Text] [Related]
7. Engineering Efferocytosis-Mimicking Nanovesicles to Regulate Joint Anti-Inflammation and Peripheral Immunosuppression for Rheumatoid Arthritis Therapy.
Yuan S; Chai Y; Xu J; Wang Y; Jiang L; Lu N; Jiang H; Wang J; Pan X; Deng J
Adv Sci (Weinh); 2024 May; ():e2404198. PubMed ID: 38810118
[TBL] [Abstract][Full Text] [Related]
8. Folate receptor-mediated targeted therapy for rheumatoid arthritis by methotrexate-phospholipid complex nano-emulsions.
Li C; Luo X; Qian C; Huang J; Yi X; Su H; Han Y
J Drug Target; 2023 Apr; 31(4):402-410. PubMed ID: 36724823
[TBL] [Abstract][Full Text] [Related]
9. Bioinspired nanogels as cell-free DNA trapping and scavenging organelles for rheumatoid arthritis treatment.
Zhu H; Kong B; Che J; Zhao Y; Sun L
Proc Natl Acad Sci U S A; 2023 Aug; 120(33):e2303385120. PubMed ID: 37549284
[TBL] [Abstract][Full Text] [Related]
10. Nanomedicine is more than a supporting role in rheumatoid arthritis therapy.
Han Y; Huang S
J Control Release; 2023 Apr; 356():142-161. PubMed ID: 36863691
[TBL] [Abstract][Full Text] [Related]
11. TRAIL-expressing cell membrane nanovesicles as an anti-inflammatory platform for rheumatoid arthritis therapy.
Shi Y; Xie F; Rao P; Qian H; Chen R; Chen H; Li D; Mu D; Zhang L; Lv P; Shi G; Zheng L; Liu G
J Control Release; 2020 Apr; 320():304-313. PubMed ID: 32004586
[TBL] [Abstract][Full Text] [Related]
12. Targeted and Combined TPCA-1-Gold Nanocage Therapy for In Vivo Treatment of Inflammatory Arthritis.
Wang Z; Yang J; Yang Y; Pu X; Zhao J; Zhang N
AAPS PharmSciTech; 2020 Nov; 21(8):298. PubMed ID: 33140225
[TBL] [Abstract][Full Text] [Related]
13. Coating nanocarriers with hyaluronic acid facilitates intravitreal drug delivery for retinal gene therapy.
Martens TF; Remaut K; Deschout H; Engbersen JF; Hennink WE; van Steenbergen MJ; Demeester J; De Smedt SC; Braeckmans K
J Control Release; 2015 Mar; 202():83-92. PubMed ID: 25634806
[TBL] [Abstract][Full Text] [Related]
14. Targeted drug-delivery systems in the treatment of rheumatoid arthritis: recent advancement and clinical status.
Gorantla S; Singhvi G; Rapalli VK; Waghule T; Dubey SK; Saha RN
Ther Deliv; 2020 Apr; 11(4):269-284. PubMed ID: 32434463
[TBL] [Abstract][Full Text] [Related]
15. Novel nano therapeutic materials for the effective treatment of rheumatoid arthritis-recent insights.
Janakiraman K; Krishnaswami V; Rajendran V; Natesan S; Kandasamy R
Mater Today Commun; 2018 Dec; 17():200-213. PubMed ID: 32289062
[TBL] [Abstract][Full Text] [Related]
16. A review of hyaluronic acid-based therapeutics for the treatment and management of arthritis.
Walvekar P; Lulinski P; Kumar P; Aminabhavi TM; Choonara YE
Int J Biol Macromol; 2024 Apr; 264(Pt 2):130645. PubMed ID: 38460633
[TBL] [Abstract][Full Text] [Related]
17. Retro-inverso d-peptide-modified hyaluronic acid/bioreducible hyperbranched poly(amido amine)/pDNA core-shell ternary nanoparticles for the dual-targeted delivery of short hairpin RNA-encoding plasmids.
Gu J; Chen X; Fang X; Sha X
Acta Biomater; 2017 Jul; 57():156-169. PubMed ID: 28442415
[TBL] [Abstract][Full Text] [Related]
18. Biomimetic NO Scavenging Hyaluronic Acid Nanoparticles Enable Targeted Delivery of MTX and Integrated Management of Rheumatoid Arthritis.
Liu Y; Luo H; Liu B; Zhou T; Zhang Z; Liu Z
Biomacromolecules; 2024 Jun; ():. PubMed ID: 38899740
[TBL] [Abstract][Full Text] [Related]
19. Microneedles loaded with cerium-manganese oxide nanoparticles for targeting macrophages in the treatment of rheumatoid arthritis.
Xia T; Zhu Y; Li K; Hao K; Chai Y; Jiang H; Lou C; Yu J; Yang W; Wang J; Deng J; Wang Z
J Nanobiotechnology; 2024 Mar; 22(1):103. PubMed ID: 38468261
[TBL] [Abstract][Full Text] [Related]
20. Controlled shielding and deshielding of gene delivery polyplexes using hydroxyethyl starch (HES) and alpha-amylase.
Noga M; Edinger D; Rödl W; Wagner E; Winter G; Besheer A
J Control Release; 2012 Apr; 159(1):92-103. PubMed ID: 22269664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
